Pharmaceutical Perspectives Of Cancer Therapeutics 2009 Edition

Description

Springer Pharmaceutical Perspectives Of Cancer Therapeutics 2009 Edition by Yi Lu Ram I. Mahato

Pharmaceutical Perspectives of Cancer Therapeutics covers a wide variety of therapeutic approaches including gene therapy immunological therapy; cancer vaccines; strategy for solid tumors as well as for hematological cancers; methods to suppress tumor angiogenesis and metastasis; development and utilization of relevant animal models; introduction of new concepts such as cancer stem cells and new technologies such as DNA and tissue microarrays; and RNA interference. In addition clinical application the development of DNA diagnosis biomarkers and cancer prevention as well as the utilization of imaging in cancer therapy are also discussed. The use of synthetic carriers such as lipids polymers and peptides for delivery and targeting of small molecules proteins and nucleic acids to cancer cells in vivo are discussed. Pharmaceutical Perspectives of Cancer Therapeutics also includes cancer therapy modality in surgery chemotherapy and radiotherapy as well as in combination or multi-modality giving our book a more focused view of cancer therapy. Table of contents : 1. Tumor microvasculature and microenvironment: Therapeutic targets for inhibition of angiogenesis and metastasis Chikezie Madu and Yi Lu* 2. Anticancer drug development AjitNarang* and Divyakant S. Desai 3. Tumor targeted macromolecular drug delivery based on the enhanced permeability and retention effect in solid tumor Takahiro Seki Jun Fang and Hiroshi Maeda* 4. Multidrug-resistance in solid tumor and its reversal Ho Lun Wong* Xiao Yu Wu and Reina Bendayan 5. Targeting of apoptosis signaling pathways and their mediators for cancer therapy Arun K. Rishi* Xinbo Zhang and Anil Wali 6. Role of telomerase in cancer therapeutics Kyung H. Choi and Michel M. Ouellette* 7. Polymeric carriers for anticancer drug delivery Dongin Kim and You Han Bae* 8. Application of nanobiotechnology in cancer therapeutics Kewal K. Jain 9. Receptor-mediated delivery of proteins and peptides to tumors Christian Dohmen and Manfred Ogris* 10. Protein transduction domain-mediated delivery of anti-cancer proteins Hiroshi Harada* and Masahiro Hiraoka 11. Current therapeutic uses of monoclonal antibodies Michael Axelson and David Gerber* 12. Cancer vaccines ZsuzsannaTabi 13. RNA interference for cancer therapy Kun Cheng* and Bin Qin 14. MicroRNAs as therapeutic targets for cancer Guofeng Cheng Michael Danquah and Ram I Mahato* 15. Targeted therapies for malignant brain tumors Matthew A. Tyler Adam Quasar Sugihara Ilya V. Ulasov and Maciej S. Lesniak* 16. The complexity of the HIF-1-dependent hypoxic response in breast cancer presents multiple avenues for therapeutic intervention Tiffany Seagroves 17. Cancer stem cells: potential mediators of therapeutic resistance and novel targets of anti-cancer treatments Hong Yan Jichao Qin and Dean G. Tang* 18. Image-guided photodynamic cancer therapy Zheng-Rong Lu* and AnaghaVaidya 19. Functional imaging of multidrug resistance and its applications Celia Gomes 20.Gene expression microarrays in cancer research Jian Yang and Weikuan Gu* 21.Clinical trials and translational applications in cancer therapy Dineo Khabele and Derrick Beech